Replies to post #2569 on BioCurex, Inc.(fka BOCX)

[Kag]

"Also we don't actually know what the licensing agreement allows Abbott to use..."

Half Full,
We do know what the BioCurex/Abbott licensing deal allows Abbott to use. The deal gives Abbott the worldwide rights to commercialize blood tests using BioCurex's RECAF technology. Abbott's goal is to further develop this technology, incorporating it into future tests ran on their automated Architect system, for use in cancer diagnosis and monitoring. It sounds like Abbott can develop as many RECAF blood tests as they want to. kag

[erthang]

I just got my phone bill!!! That phone interview cost me $55.00! There is definitely a vacancy for the position of shareholder spokesperson!

[erthang]

Half-full - did you ever find out how much Abbott paid in upfront cash?